PER
Click for more information
1.23% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-65

  1. kosenar
    2,193 Posts.
    lightbulb Created with Sketch. 72
    clock Created with Sketch.
    24/04/21
    16:37
    Post #: 52699516
    Sorry if this has already been asked!

    Are any of the patients who have received this successful process, still having ongoing treatment?

    And if so, has any further data been produced?

    Regards
    ANP Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.001(1.23%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.